Author | Bob Alaburda, Associate Editorial Director

Bob Alaburda, Associate Editorial Director

Articles

Understanding the physiology behind SGLT2 inhibitors

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), describes a sodium-glucose cotransporter-2 inhibitor in a dvm360 interview.

What to expect with the updates to ACVAA's small animal anesthesia and sedation monitoring guidelines for 2025

Lydia Love, DVM, DACVAA, discusses the rationale, technological advances, and training imperatives that underpin the updated 2025 ACVAA guidelines

Highly pathogenic avian influenza and biosecurity

Christopher Lee, DVM, MPH, DACVPM, explains why early detection and enhanced biosecurity are essential for mitigating the spread of highly pathogenic avian influenza

5 Ways to pick up on your pet's vision changes

Share this advice from Alex Sigmund, DVM, DACVO, with pet parents to help catch vision issues early and ensure timely care

baltimore conference logo